Interdisciplinary model of care (RADICALS) for early detection and management of chronic obstructive pulmonary disease (COPD) in Australian primary care: Study protocol for a cluster randomised controlled trial

BMJ Open

Volumn 7, Issue 9, 2017, Pages

  Liang, Jenifer ^a   Abramson, Michael J ^a   Zwar, Nicholas ^b,c   Russell, Grant ^a   Holland, Anne E ^d,e,f   Bonevski, Billie ^g   Mahal, Ajay ^a,h   Van Hecke, Benjamin ⁱ   Phillips, Kirsten ^j   Eustace, Paula ^k   Paul, Eldho ^a,l   Petrie, Kate ^a   Wilson, Sally ^a   George, Johnson ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF WOLLONGONG   (Australia)

^d LA TROBE UNIVERSITY   (Australia)

^e Alfred Health ^*  (Australia)

^f AUSTIN HOSPITAL   (Australia)

^g UNIVERSITY OF NEWCASTLE   (Australia)

^h UNIVERSITY OF MELBOURNE   (Australia)

ⁱ Boehringer Ingelheim Pty Ltd   (Australia)

^j Lung Foundation Australia   (Australia)

^k Eastern Melbourne PHN (EMPHN)   (Australia)

^l ALFRED HOSPITAL   (Australia)

more..

Author keywords

chronic obstructive pulmonary disease; COPD; education; home medicines review; primary care; pulmonary rehabilitation; smoking

Indexed keywords

ARTICLE; AUSTRALIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PROTOCOL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; HUMAN; INTERDISCIPLINARY RESEARCH; MAJOR CLINICAL STUDY; MODEL; PRIMARY MEDICAL CARE; PULMONARY REHABILITATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SMOKING; SPIROMETRY; ST. GEORGE RESPIRATORY QUESTIONNAIRE; ADULT; AGED; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; MEDICATION COMPLIANCE; METHODOLOGY; MIDDLE AGED; NONBIOLOGICAL MODEL; PATHOPHYSIOLOGY; PATIENT CARE; PRIMARY HEALTH CARE; PROCEDURES; SMOKING CESSATION; UTILIZATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; HEALTH RESOURCES; HUMANS; MEDICATION ADHERENCE; MIDDLE AGED; MODELS, ORGANIZATIONAL; PATIENT CARE TEAM; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESEARCH DESIGN; SMOKING CESSATION;

EID: 85034810832     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2017-016985     Document Type: Article

References (75)

1. World Health Organisation. World Health Statistics. Geneva: World Health Organisation, 2008.
2. McDonald C F, Glasgow N. The Burden of Obstructive Lung Disease (BOLD) study in Australia. Med J Aust 2013;198:124-5.
3. Toelle BG, Xuan W, Bird TE, et al. Respiratory symptoms and illness in older Australians: the Burden of Obstructive Lung Disease (BOLD) study. Med J Aust 2013;198:144-8.
4. Australian Institute of Health and Welfare. How many die from COPD? http://www.aihw.gov.au/copd/mortality/(accessed 3 Aug 2015).
5. Australian Institute of Health and Welfare. What role do hospitals play in treating COPD? http://www.aihw.gov.au/copd/treatment-by-hospitals/(accessed 3 Aug 2015).
6. Australian Institute of Health and Welfare. What role do GPs play in treating COPD? http://www.aihw.gov.au/copd/treatment-by-gps/(accessed 3 Aug 2015).
7. Global Initiative for Chronic Obstructive Lung Disease. 2014. GOLD 2014 Global Strategy for the Diagnosis, Management, and Prevention of COPD. http://goldcopd. org/(accessed 6 Jan 2015).
8. Lundbäck B, Lindberg A, Lindström M, et al. Not 15 but 50% of smokers develop COPD?-Report from the obstructive lung disease in Northern Sweden studies. Respir Med 2003;97:115-22.
9. Abramson MJ, Crockett AJ, Dabscheck E, et al. The COPD-X Plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease. Australia: Lung Foundation Australia and Thoracic Society of Australia & New Zealand, 2014.
10. Abramson MJ, Frith P, Yang I, et al. COPD-X Concise Guide for Primary Care. Brisbane, Australia: Lung Foundation Australia and Thoracic Society of Australia & New Zealand, 2016.
11. Davis KJ, Landis SH, Oh YM, et al. Continuing to Confront COPD International Physician Survey: physician knowledge and application of COPD management guidelines in 12 countries. Int J Chron Obstruct Pulmon Dis 2015;10:39-55.
12. Bourbeau J, Sebaldt RJ, Day A, et al. Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: the CAGE study. Can Respir J 2008;15:13-19.
13. Decramer M, Bartsch P, Pauwels R, et al. Management of COPD according to guidelines. A national survey among Belgian physicians. Monaldi Arch Chest Dis 2003;59:62-80.
14. Desalu OO, Onyedum CC, Adeoti AO, et al. Guideline-based COPD management in a resource-limited setting-physicians' understanding, adherence and barriers: a cross-sectional survey of internal and family medicine hospital-based physicians in Nigeria. Prim Care Respir J 2013;22:79-85.
15. Fritsch K, Jacot ML, Klarer A, et al. Adherence to the Swiss guidelines for management of COPD: experience of a Swiss teaching hospital. Swiss Med Wkly 2005;135(7-8):116-21.
16. Glaab T, Vogelmeier C, Hellmann A, et al. Guideline-based survey of outpatient COPD management by pulmonary specialists in Germany. Int J Chron Obstruct Pulmon Dis 2012;7:101-8.
17. Hernandez P, Balter MS, Bourbeau J, et al. Canadian practice assessment in chronic obstructive pulmonary disease: respiratory specialist physician perception versus patient reality. Can Respir J 2013;20:97-105.
18. Jans M P, Schellevis FG, van Hensbergen W, et al. Management of asthma and COPD patients: feasibility of the application of guidelines in general practice. Int J Qual Health Care 1998;10:27-34.
19. Johnston K, Grimmer-Somers K, Young M, et al. Which chronic obstructive pulmonary disease care recommendations have low implementation and why? A pilot study. BMC Res Notes 2012;5:652.
20. Jones RC, Dickson-Spillmann M, Mather MJ, et al. Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit. Respir Res 2008;9:62.
21. Price D, West D, Brusselle G, et al. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns. Int J Chron Obstruct Pulmon Dis 2014;9:889-904.
22. Lung Foundation Australia. 2011. The Australian Lung Foundation position paper on the use of COPD screening devices for targeted COPD case fnding in community settings. http://lungfoundation. com.au/wp-content/uploads/2014/02/Position-Paper.pdf (accessed 18 Aug 2015).
23. Matheson MC, Abeysena C, Raven JM, et al. How have we been managing chronic obstructive pulmonary disease in Australia? Intern Med J 2006;36:92-9.
24. Zwar NA, Hermiz O, Comino E, et al. Care of patients with a diagnosis of chronic obstructive pulmonary disease: a cluster randomised controlled trial. Med J Aust 2012;197:394-8.
25. Han MK, Kim MG, Mardon R, et al. Spirometry utilization for COPD: how do we measure up? Chest 2007;132:403-9.
26. Joo MJ, Au DH, Lee TA. Use of spirometry in the diagnosis of chronic obstructive pulmonary disease and efforts to improve quality of care. Transl Res 2009;154:103-10.
27. Joo MJ, Lee TA, Weiss KB. Geographic variation of spirometry use in newly diagnosed COPD. Chest 2008;134:38-45.
28. Access Economics. 2008. Economic impact of COPD and cost effective solutions. http://www.rnig.org.au/docs/EconomicImpactofC OPDandCostEffectiveSolutions-226.pdf (accessed 8 Aug 2015).
29. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-50.
30. Ta M, George J. Management of chronic obstructive pulmonary disease in Australia after the publication of national guidelines. Intern Med J 2011;41:263-70.
31. Lacasse Y, Goldstein R, Lasserson TJ, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006;4:CD003793.
32. Marks G, Reddel H, et al, Australian Institute of Health and Welfare. 2013. Monitoring pulmonary rehabilitation and long-term oxygen therapy for people with chronic obstructive pulmonary disease (COPD): a discussion paper. Canberra. Australian Institute of Health and Welfare. Cat. no. ACM 29.
33. Yohannes AM, Connolly MJ. Pulmonary rehabilitation programmes in the UK: a national representative survey. Clin Rehabil 2004;18:444-9.
34. Brooks D, Sottana R, Bell B, et al. Characterization of pulmonary rehabilitation programs in Canada in 2005. Can Respir J 2007;14:87-92.
35. Johnston KN, Young M, Grimmer KA, et al. Barriers to, and facilitators for, referral to pulmonary rehabilitation in COPD patients from the perspective of Australian general practitioners: a qualitative study. Prim Care Respir J 2013;22:319-24.
36. Benzo R, Wetzstein M, Neuenfeldt P, et al. Implementation of physical activity programs after COPD hospitalizations: lessons from a randomized study. Chron Respir Dis 2015;12:5-10.
37. Keating A, Lee A, Holland AE. What prevents people with chronic obstructive pulmonary disease from attending pulmonary rehabilitation? A systematic review. Chron Respir Dis 2011;8:89-99.
38. Abramson MJ, Kamali MS, Holland AE, et al. Perceptions of pulmonary rehabilitation by health professionals and culturally and linguistically diverse COPD patients. American Thoracic Society 2013 International Conference. Pennsylvania Convention Centre: American Thoracic Society:A5127-27.
39. Zwarenstein M, Goldman J, Reeves S. Interprofessional collaboration: effects of practice-based interventions on professional practice and healthcare outcomes. Cochrane Database Syst Rev 2009;3:CD000072.
40. Chavannes NH, Grijsen M, van den Akker M, et al. Integrated disease management improves one-year quality of life in primary care COPD patients: a controlled clinical trial. Prim Care Respir J 2009;18:171-6.
41. Kruis AL, Smidt N, Assendelft WJ, et al. Integrated disease management interventions for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2013;10:CD009437.
42. Kruis AL, Boland MR, Assendelft WJ, et al. Effectiveness of integrated disease management for primary care chronic obstructive pulmonary disease patients: results of cluster randomised trial. BMJ 2014;349:g5392.
43. Australian Government Department of Health. 2017. Primary Health Care in Australia. http://www.health.gov.au/internet/publications/publishing.nsf/Content/NPHC-Strategic-Framework~phc-australia (accessed 25 May 2017).
44. Australian Government Department of Human Services. Education guide-chronic disease GP management plans and team care arrangements. 2017 https://www.humanservices.gov.au/health-professionals/enablers/education-guide-chronic-disease-gp-management-plans-and-team-care (accessed 25 May 2017).
45. Coupland C, DiGuiseppi C. The design and use of cluster randomised controlled trials in evaluating injury prevention interventions: part 2. design effect, sample size calculations and methods for analysis. Inj Prev 2010;16:132-6.
46. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38.
47. Frith P, Crockett A, Beilby J, et al. Simplifed COPD screening: validation of the PiKo-6 in primary care. Prim Care Respir J 2011;20:190-8.
48. Zwar N, Richmond R, Borland R, et al. Supporting smoking cessation: a guide for health professionals: The Royal Australian College of General Practitioners, 2011.
49. The Australian Lung Foundation. Better living with chronic obstructive pulmonary disease-a patient guide. 2nd ed. Queensland: The State of Queensland (Queensland Health) and The Australian Lung Foundation, 2012.
50. Thomas D, Abramson MJ, Bonevski B, et al. A pharmacist-led system-change smoking cessation intervention for smokers admitted to Australian public hospitals (GIVE UP FOR GOOD): study protocol for a randomised controlled trial. Trials 2013;14:148.
51. Holland AE, Mahal A, Hill CJ, et al. Home-based rehabilitation for COPD using minimal resources: a randomised, controlled equivalence trial. Thorax 2017;72:57-65.
52. Pharmaceutical Society of Australia. Guidelines for pharmacists providing Home Medicines Review (HMR) services. 2011.
53. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
54. Borland R, Yong HH, O'Connor RJ, et al. The reliability and predictive validity of the heaviness of Smoking Index and its two components: fndings from the International tobacco control four country study. Nicotine Tob Res 2010;12 Suppl:S45-50.
55. Velicer W F, Diclemente CC, Rossi JS, et al. Relapse situations and self-effcacy: an integrative model. Addict Behav 1990;15:271-83.
56. Biener L, Abrams DB. The contemplation ladder: validation of a measure of readiness to consider smoking cessation. Health Psychol 1991;10:360-5.
57. Abrams DB, Niaura R, Brown RA, et al. Assessment to inform smoking cessation treatment. the tobacco dependence treatment handbook: a guide to best practices. 1st edn. New York: Guilford Press, 2003.
58. Zigmond AS, Snaith R P. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
59. Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airfow limitation. the St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-7.
60. Jones PW, Harding G, Berry P, et al. Development and frst validation of the COPD assessment test. Eur Respir J 2009;34:648-54.
61. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airfow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-12.
62. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988;93:580-6.
63. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol group. Ann Med 2001;33:337-43.
64. George J, Mackinnon A, Kong DC, et al. Development and validation of the Beliefs and Behaviour Questionnaire (BBQ). Patient Educ Couns 2006;64:50-60.
65. Baker R. Development of a questionnaire to assess patients' satisfaction with consultations in general practice. Br J Gen Pract 1990;40:487-90.
66. Stewart DC, George J, Bond CM, et al. Exploring patients' perspectives of pharmacist supplementary prescribing in Scotland. Pharm World Sci 2008;30:892-7.
67. Tan EC, Stewart K, Elliott RA, et al. Pharmacist consultations in general practice clinics: the Pharmacists in Practice Study (PIPS). Res Social Adm Pharm 2014;10:623-32.
68. Carter SR, Chen T F, White L. Home medicines reviews: a quantitative study of the views of recipients and eligible non-recipients. Int J Pharm Pract 2012;20:209-17.
69. Adams G, Gulliford MC, Ukoumunne OC, et al. Patterns of intra-cluster correlation from primary care research to inform study design and analysis. J Clin Epidemiol 2004;57:785-94.
70. Løkke A, Lange P, Scharling H, et al. Developing COPD: a 25 year follow up study of the general population. Thorax 2006;61:935-9.
71. Viney R, Norman R, King MT, et al. Time trade-off derived EQ-5D weights for Australia. Value Health 2011;14:928-36.
72. Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull 2010;96:5-21.
73. Goossens LM, Leimer I, Metzdorf N, et al. Does the 2013 GOLD classifcation improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial. BMC Pulm Med 2014;14:163.
74. Kim J, Yoon HI, Oh YM, et al. Lung function decline rates according to GOLD group in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2015;10:1819-27.
75. Soriano JB, Lamprecht B, Ramírez AS, et al. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data. Lancet Respir Med 2015;3:443-50.